Exciting current CLL trials taking place in the UK
Upcoming amyloidosis clinical trial data to look forward to at ASH 2017
Which CLL patients would benefit from intensive therapy?
Personalising treatment to the biology of the NHL patient
The pivotal ZUMA-1 trial for NHL